Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

PAVmed (PAVM) Accumulated Depreciation & Amortization (2016 - 2025)

PAVmed has reported Accumulated Depreciation & Amortization over the past 6 years, most recently at $1.4 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 8.38% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, up 8.38%, while the annual FY2025 figure was $1.4 million, 8.38% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $1.4 million at PAVmed, up from $1.3 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $1.7 million in Q4 2023 and troughed at $138000.0 in Q4 2021.
  • A 5-year average of $1.1 million and a median of $1.3 million in 2024 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 485.51% in 2022 and later dropped 27.11% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $138000.0 in 2021, then skyrocketed by 485.51% to $808000.0 in 2022, then soared by 112.75% to $1.7 million in 2023, then fell by 27.11% to $1.3 million in 2024, then grew by 8.38% to $1.4 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for PAVM at $1.4 million in Q4 2025, $1.3 million in Q4 2024, and $1.7 million in Q4 2023.